Susquehanna International Group, LLP Frequency Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	SELL	$0.33 - $0.48 $5,775 - $8,400	-17,500 Reduced 57.95%	12,700 $4,000
Q1 2023 May 16, 2023	BUY	$0.44 - $5.47 $13,288 - $165,194	30,200 New	30,200 $15,000
Q3 2022 Nov 14, 2022	SELL	$1.46 - $2.55 $55,480 - $96,900	-38,000 Reduced 56.46%	29,300 $52,000
Q2 2022 Aug 15, 2022	BUY	$1.03 - $2.03 $45,835 - $90,334	44,500 Added 195.18%	67,300 $101,000
Q1 2022 May 16, 2022	SELL	$1.7 - $5.72 $44,880 - $151,008	-26,400 Reduced 53.66%	22,800 $48,000
Q4 2021 Feb 14, 2022	SELL	$4.95 - $7.11 $247,005 - $354,789	-49,900 Reduced 50.35%	49,200 $252,000
Q3 2021 Nov 15, 2021	SELL	$6.96 - $9.25 $1.04 Million - $1.38 Million	-149,600 Reduced 60.15%	99,100 $700,000
Q2 2021 Aug 11, 2021	BUY	$8.05 - $11.61 $537,740 - $775,548	66,800 Added 36.72%	248,700 $2.48 Million
Q1 2021 May 17, 2021	BUY	$7.99 - $55.01 $1.08 Million - $7.43 Million	135,100 Added 288.68%	181,900 $1.73 Million
Q4 2020 Feb 16, 2021	BUY	$18.65 - $40.0 $872,819 - $1.87 Million	46,800 New	46,800 $1.65 Million

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.